Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
CIA Adds Fourth Pillar to AI Strategy, CAIO Says
Lakshmi Raman says the new pillar marks a strategic shift toward embedding AI more deeply into the CIA’s day-to-day mission execution.
3m read -
FEHRM CTO Targets Two-Year Cloud Migration for Federal EHR
Lance Scott touts new EHR tech advancements, including cloud migration, expanded data exchange and AI integration to improve care delivery.
4m read -
AI Enables Coast Guard’s Workforce to Transform Operations
The Coast Guard’s Deputy CIO Brian Campo delves into the ways AI is pushing the service to rethink its core services, workforce and operations.
14m watch -
New Army Acquisition Plan Cites Autonomy, Predictive Analytics
Officials outline how the Army Transformation Initiative signals a broader shift toward efficiency with tech and acquisition reform.
4m read
